Immunic, Inc. (IMUX)
NASDAQ
Market Cap
$88.34M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
353 of 809
Rank in Industry
218 of 445
Largest Insider Buys in Sector
IMUX Stock Price History Chart
IMUX Stock Performance
About Immunic, Inc.
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of ROR?t; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor induced colitis, and other intestinal barrier function diseases. Immunic, Inc. is headquartered in New York, New York.
Insider Activity of Immunic, Inc.
Over the last 12 months, insiders at Immunic, Inc. have bought $18,333 and sold $0 worth of Immunic, Inc. stock.
On average, over the past 5 years, insiders at Immunic, Inc. have bought $139,669 and sold $102,745 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Vitt Daniel (President and CEO) — $18,333.
The last purchase of 14,000 shares for transaction amount of $18,333 was made by Vitt Daniel (President and CEO) on 2024‑02‑26.
List of Insider Buy and Sell Transactions, Immunic, Inc.
| 2024-02-26 | Vitt Daniel | President and CEO | 14,000 0.0159% | $1.31 | $18,333 | -0.78% | ||
| 2023-05-15 | Whaley Glenn | Chief Financial Officer | 5,000 0.0114% | $1.75 | $8,750 | -22.16% | ||
| 2022-12-14 | Neermann Joerg | director | 47,000 0.1472% | $1.26 | $59,032 | +28.97% | ||
| 2022-12-13 | Neermann Joerg | director | 35,000 0.1105% | $1.25 | $43,610 | +31.05% | ||
| 2022-11-23 | Neermann Joerg | director | 18,000 0.0578% | $1.39 | $25,020 | +19.85% | ||
| 2022-11-22 | Vitt Daniel | President and CEO | 8,000 0.0259% | $1.35 | $10,799 | +24.05% | ||
| 2022-11-07 | Whaley Glenn | Chief Financial Officer | 5,000 0.0164% | $1.50 | $7,475 | +13.64% | ||
| 2022-06-03 | Vitt Daniel | President and CEO | 5,000 0.0151% | $3.10 | $15,500 | -43.22% | ||
| 2022-06-03 | Whaley Glenn | Chief Financial Officer | 3,500 0.0104% | $3.04 | $10,658 | -43.22% | ||
| 2022-05-12 | Muehler Andreas | Chief Medical Officer | 3,500 0.0115% | $5.10 | $17,850 | -59.81% | ||
| 2022-05-12 | Nash Duane | Executive Chairman | 10,000 0.0323% | $5.03 | $50,300 | -59.81% | ||
| 2022-05-12 | Whaley Glenn | Chief Financial Officer | 3,000 0.0098% | $5.08 | $15,240 | -59.81% | ||
| 2021-08-10 | Vitt Daniel | President and CEO | 1,000 0.0039% | $9.60 | $9,600 | -5.42% | ||
| 2021-08-10 | Nash Duane | Executive Chairman | 1,000 0.004% | $9.80 | $9,800 | -5.42% | ||
| 2021-08-10 | Whaley Glenn | PFO and PAO | 1,500 0.006% | $9.85 | $14,775 | -5.42% | ||
| 2021-05-12 | Nash Duane | Executive Chairman | 4,000 0.0186% | $12.75 | $51,000 | -21.89% | ||
| 2021-03-02 | Muehler Andreas | Chief Medical Officer | 10,006 0.046% | $15.54 | $155,493 | -34.17% | ||
| 2021-03-02 | Whaley Glenn | PFO and PAO | 1,000 0.0049% | $16.48 | $16,480 | -34.17% | ||
| 2020-08-10 | Whaley Glenn | PFO and PAO | 1,000 0.0051% | $18.96 | $18,960 | -20.03% | ||
| 2020-07-21 | Sale | Vitt Daniel | Chief Executive Officer | 1,300 0.0067% | $15.62 | $20,310 | -1.12% |
Insider Historical Profitability
39.15%
| Vitt Daniel | President and CEO | 390877 0.4191% | $0.98 | 4 | 2 | <0.0001% |
| Muehler Andreas | Chief Medical Officer | 297986 0.3314% | $0.98 | 2 | 0 | <0.0001% |
| Groeppel Manfred | Chief Operating Officer | 278830 0.3101% | $0.98 | 0 | 2 | |
| Winters Terence E. | Co-Chairman and CEO | 194966 0.2168% | $0.98 | 2 | 0 | +75.81% |
| Neermann Joerg | director | 100000 0.1112% | $0.98 | 3 | 0 | +26.62% |
| SEARS LOWELL | director | 58572 0.0651% | $0.98 | 2 | 0 | |
| Whaley Glenn | Chief Financial Officer | 25510 0.0284% | $0.98 | 7 | 0 | <0.0001% |
| Nash Duane | Executive Chairman | 22032 0.0245% | $0.98 | 5 | 1 | +26.35% |
| BIENAIME JEAN JACQUES | director | 18500 0.0206% | $0.98 | 6 | 2 | +135.14% |
| CROXFORD PHILIP M | director | 17841 0.0198% | $0.98 | 1 | 0 | |
| DUNN JOHN MICHAEL | General Counsel and Secretary | 11885 0.0132% | $0.98 | 3 | 0 | +35.39% |
| Hasnain Faheem | director | 4500 0.005% | $0.98 | 2 | 1 | |
| Ashley Robert A. | Chief Technical Officer, EVP | 2000 0.0022% | $0.98 | 1 | 0 | +69.53% |
| Stern Aron | See Remarks | 1333 0.0015% | $0.98 | 1 | 0 | |
| Cohen Cheryl | director | 0 0% | $0.98 | 1 | 1 | +12.02% |
| Satter Muneer A | 0 0% | $0.98 | 22 | 3 | +61.06% | |
| Halperin Errol R. | director | 0 0% | $0.98 | 2 | 1 | |
| Godshall Douglas Evan | director | 0 0% | $0.98 | 2 | 1 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Bvf Inc Il | $11.75M | 9.88 | 8.9M | New | +$11.75M | 0.09 | |
| Avidity Partners Management Lp | $11.75M | 9.88 | 8.9M | New | +$11.75M | 0.43 | |
| Soleus Capital Management, L.P. | $9.63M | 8.1 | 7.29M | +2,331% | +$9.23M | 0.09 | |
| Janus Henderson | $9.27M | 7.76 | 6.99M | New | +$9.27M | 0.01 | |
| Adage Capital Partners Gp L L C | $7.38M | 6.21 | 5.59M | New | +$7.38M | 0.01 | |
| RTW Investments, LP | $6.03M | 5.07 | 4.57M | +5.36% | +$306,849.82 | 0.09 | |
| The Vanguard Group | $4.48M | 3.77 | 3.39M | +100.71% | +$2.25M | <0.0001 | |
| Gratus Capital | $2.71M | 2.28 | 2.05M | +5.74% | +$146,986.00 | 0.13 | |
| Omega Fund Management Llc | $2.36M | 1.99 | 1.79M | 0% | +$0 | 1.75 | |
| Ikarian Capital LLC | $2.13M | 1.79 | 1.61M | New | +$2.13M | 0.61 | |
| Geode Capital Management | $1.18M | 0.99 | 895,646 | +114.47% | +$631,078.43 | <0.0001 | |
| Renaissance Technologies | $986,000.00 | 0.83 | 747,271 | +898.95% | +$887,295.89 | <0.01 | |
| 683 Capital Management Llc | $923,077.00 | 0.78 | 699,301 | New | +$923,077.00 | 0.1 | |
| BlackRock | $872,855.00 | 0.73 | 661,254 | +82.6% | +$394,848.83 | <0.0001 | |
| Boothbay Fund Management LLC | $559,049.00 | 0.47 | 423,522 | +422.28% | +$452,008.89 | 0.02 | |
| Logos Global Management Lp | $555,963.00 | 0.47 | 421,184 | 0% | +$0 | 0.06 | |
| Two Sigma | $336,089.00 | 0.28 | 254,613 | +118.56% | +$182,316.99 | <0.01 | |
| Northern Trust | $317,114.00 | 0.27 | 240,238 | +46.1% | +$100,054.63 | <0.0001 | |
| Acadian Asset Management | $316,000.00 | 0.27 | 239,962 | -57.1% | -$420,534.87 | <0.01 | |
| Two Sigma Advisers LP | $228,780.00 | 0.19 | 173,318 | +17.57% | +$34,188.04 | <0.0001 | |
| Ubs Oconnor Llc | $221,344.00 | 0.19 | 167,685 | -72.06% | -$570,964.16 | 0.02 | |
| Susquehanna International Group | $174,834.00 | 0.15 | 132,450 | -60.46% | -$267,303.96 | <0.0001 | |
| State Street | $172,264.00 | 0.15 | 130,503 | +3.74% | +$6,204.00 | <0.0001 | |
| Millennium Management LLC | $158,471.00 | 0.13 | 120,054 | New | +$158,471.00 | <0.0001 | |
| Bank of America | $156,572.00 | 0.13 | 118,615 | +36.53% | +$41,891.57 | <0.0001 | |
| Bridgeway Capital Management | $135,696.00 | 0.11 | 102,800 | -8.87% | -$13,200.00 | <0.01 | |
| Xtx Topco Ltd | $81,437.00 | 0.07 | 61,695 | +45.92% | +$25,626.35 | <0.01 | |
| Connor Clark & Lunn Investment Management Ltd | $78,598.00 | 0.07 | 59,544 | New | +$78,598.00 | <0.0001 | |
| Jane Street Capital | $77,250.00 | 0.07 | 58,523 | New | +$77,250.00 | <0.0001 | |
| Schonfeld Group | $69,960.00 | 0.06 | 53,000 | -59.14% | -$101,244.00 | <0.0001 | |
| D. E. Shaw & Co. | $69,003.00 | 0.06 | 52,275 | New | +$69,003.00 | <0.0001 | |
| Marshall Wace | $65,378.00 | 0.06 | 49,529 | +156.91% | +$39,929.83 | <0.0001 | |
| Tower Research Capital | $56,208.00 | 0.05 | 42,582 | +803.88% | +$49,989.51 | <0.01 | |
| Squarepoint Ops LLC | $41,348.00 | 0.04 | 31,324 | New | +$41,348.00 | <0.0001 | |
| BNY Mellon | $41,947.00 | 0.04 | 31,778 | +17.53% | +$6,256.81 | <0.0001 | |
| Morgan Stanley | $40,008.00 | 0.03 | 30,309 | +84.98% | +$18,379.74 | <0.0001 | |
| Sweet Financial Partners Llc | $39,374.00 | 0.03 | 29,829 | 0% | +$0 | 0.01 | |
| Simplex Trading Llc | $39,000.00 | 0.03 | 29,764 | New | +$39,000.00 | <0.01 | |
| Dimensional Fund Advisors | $38,112.00 | 0.03 | 28,873 | 0% | +$0 | <0.0001 | |
| Charles Schwab | $33,000.00 | 0.03 | 25,000 | 0% | +$0 | <0.0001 | |
| American Century Investments | $27,643.00 | 0.02 | 20,942 | 0% | +$0 | <0.0001 | |
| Summit Trail Advisors | $24,552.00 | 0.02 | 18,600 | New | +$24,552.00 | <0.01 | |
| Virtu Financial Llc | $25,000.00 | 0.02 | 19,088 | New | +$25,000.00 | <0.01 | |
| Goldman Sachs | $18,234.00 | 0.02 | 13,814 | New | +$18,234.00 | <0.0001 | |
| Level Four Advisory Services Llc | $17,663.00 | 0.01 | 11,775 | 0% | +$0 | <0.01 | |
| Balboa Wealth Partners | $15,840.00 | 0.01 | 12,000 | 0% | +$0 | 0.01 | |
| TWO SIGMA SECURITIES LLC | $14,804.00 | 0.01 | 11,215 | New | +$14,804.00 | <0.0001 | |
| Private Advisor Group | $13,200.00 | 0.01 | 10,000 | 0% | +$0 | <0.0001 | |
| Vontobel Holding Ltd | $13,200.00 | 0.01 | 10,000 | New | +$13,200.00 | <0.0001 | |
| UBS | $12,101.00 | 0.01 | 9,167 | -11.69% | -$1,602.55 | <0.0001 |